NEW YORK (GenomeWeb News) – Genetic test developer DxNA said today that the US Food and Drug Administration has granted Emergency Use Authorization (EUA) for the firm's PCR-based test for 2009 H1N1 influenza.

The EUA for DxNA's GeneSTAT detection platform is a legal means that allows FDA to authorize new medical devices during medical emergencies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.